We improve the quality of life by creating new medicines

RUS | ENG

+7 (495) 925-30-74

About us
Manufacturing
- API & FDF Experimental Producton
- Biotechnological Producton (BioIntegrator)
Portfolio
Business Incubator
News
Contacts

+7 (495) 925-30-74

About us
Manufacturing
- API & FDF Experimental Producton
- Biotechnological Producton (BioIntegrator)
Portfolio
Business Incubator
News
Contacts

+7 (495) 925-30-74

Home >> Gallery >> 2014

2014

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

COMPANY NEWS

24.03.2021 Avifavir obtains its first registration in Asia

10.03.2021 Chromis published results of a multi-center open label post-marketing clinical study in 940 COVID-19 patients confirming efficacy of Avifavir at CROI2021

20.11.2020 The international expert community highlights the efficacy and safety of Avifavir in COVID-19 treatment

09.11.2020 Avifavir will be made available to outpatients free of charge for the treatment of COVID-19

24.09.2020 RDIF and ChemRar to supply Avifavir to 17 countries

all news

Copyright © 2021 HTC "Chemrar"